Lv55
1270 积分 2024-04-17 加入
ICH M12 Drug Interaction Studies: Summary of the Efforts to Achieve Global Convergence
5小时前
待确认
Approaches to Improve the Translation of Safety, Pharmacokinetics and Therapeutic Index of ADCs
8天前
已完结
Impact of Organ Impairment on the Pharmacokinetics of Therapeutic Peptides and Proteins
1个月前
已完结
A Model‐Based Approach to Quantify the Time‐Course of Anti‐Drug Antibodies for Therapeutic Proteins
1个月前
已完结
Model‐Informed Drug Development: Current US Regulatory Practice and Future Considerations
1个月前
已完结
A Challenge for Clinical Pharmacologists: How Can We Measure Scientific Impact of Publications in Drug Development and in Regulatory Decision Making?
1个月前
已完结
Clinical Aspects of Transporter‐Mediated Drug–Drug Interactions
1个月前
已完结
1413. A Phase IIa Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of Encochleated Amphotericin B in Patients with Mucocutaneous (Esophogeal, Oropharyngeal, Vulvovaginal) Candidiasis Who are Refractory or Intolerant to Standard Non-Intravenous Therapies
1个月前
已完结
Machine Learning for Prediction of Drug Concentrations: Application and Challenges
1个月前
已完结
A 2024 Update on US FDA Implementation of Partial Area Under the Curve Into Bioavailability and Bioequivalence Assessments
1个月前
已完结
皖公网安备34019202002308
